why choose us

300×250 Ad Slot

Research Article: A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer

Date Published: 2023-09-18

Introduction:
Prostate cancer (PCa) is currently one of the leading causes of cancer-specific death in males, accounting for approximately , fatalities globally each year. Androgen deprivation therapy (ADT), the cornerstone of care for people with locally or metastatic hormone-sensitive prostate cancer (HSPC), slows the growth of PCa by lowering the level of circulating testosterone. But most patients who received ADT eventually developed to castration-resistant prostate cancer (CRPC), which has a median survival period of just…

Read more

300×250 Ad Slot